Abstract
Richter syndrome, a transformation of chronic lymphocytic leukemia (CLL) into a diffuse large B-cell lymphoma, is a rare complication of patients treated with chemo-immunotherapy. Richter syndrome might be both clonally related or unrelated to the underlying CLL and often showed mutations of the TP53 and NOTCH1 genes. Recently, ibrutinib was approved for patients with relapsed/refractory CLL or for untreated CLL patients with del 17p or TP53 mutation. The clinical picture, pathology, and genetics of Richter transformation after IBR treatment are largely unknown. Here, we report 2 cases of Richter transformation after Ibrutinib treatment. As just reported by previous report, Richter syndrome developing after ibrutinib therapy lacked resistance mutations of the BTK and PLCG2 genes, which are clonally related to the pre-existent CLL phase representing transformation from CLL. Richter syndrome after ibrutinib seems to have some peculiar clinical findings as the bone marrow predilection, severe hypercalcemia, and a more aggressive outcome.
References
May 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Apostolia-Maria TsimberidouMichael J Keating
Sep 27, 2007·The American Journal of Surgical Pathology·Zhengrong MaoAndreas Rosenwald
May 22, 2008·British Journal of Haematology·Davide RossiGianluca Gaidano
Jun 11, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Davide RossiGianluca Gaidano
Jan 27, 2011·Blood·Davide RossiGianluca Gaidano
Jan 24, 2013·Leukemia & Lymphoma·Davide Rossi
Jul 12, 2013·British Journal of Haematology·Sameer A ParikhTait D Shanafelt
Jan 15, 2014·Blood·Sameer A ParikhTait D Shanafelt
Mar 25, 2014·Nature Reviews. Cancer·Rudi W HendriksLaurens P Kil
Jul 17, 2015·JAMA Oncology·Kami J MaddocksJennifer A Woyach
Sep 1, 2015·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EichhorstUNKNOWN ESMO Guidelines Committee
Apr 5, 2016·Seminars in Oncology·Davide Rossi, Gianluca Gaidano
May 21, 2016·Nature Communications·Jan A BurgerCatherine J Wu
Oct 25, 2017·Annals of Hematology·Maliha KhanPhilip A Thompson
Citations
Jul 7, 2018·Leukemia & Lymphoma·Alankrita TanejaClare Sun
Jan 25, 2020·Annual Review of Pathology·Ferran NadeuElías Campo
Jul 7, 2019·Nature Reviews. Clinical Oncology·Francesc Bosch, Riccardo Dalla-Favera
Apr 10, 2021·Medicine·Elena Chertok ShachamAvraham Ishay
Jul 15, 2021·Pathology Oncology Research : POR·Róbert SzászÁrpád Illés